Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06909136
What this trial is testing

Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis

Who this might be right for
Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly
Suzhou Junjing BioSciences Co., Ltd. 33
Not applicableLooking for participantsNCT07774936
What this trial is testing

Fetal Health Locus of Control, Maternal Anxiety, and Cardiotocography in High-Risk Pregnancies

Who this might be right for
High-risk Pregnancy
Istanbul Training and Research Hospital 150
Early research (Phase 1)Looking for participantsNCT06108492
What this trial is testing

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 170
Not applicableStudy completedNCT02781428
What this trial is testing

To Detect the Sensitivity of the UroMark Assay

Who this might be right for
Bladder Cancer
University College, London 1,643
Not applicableStudy completedNCT02413359
What this trial is testing

High Risk Populations Among COPD Patients in Japan

Who this might be right for
COPD
AstraZeneca 1,016
Large-scale testing (Phase 3)Ended earlyNCT03921996
What this trial is testing

Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 57
Large-scale testing (Phase 3)Study completedNCT01191489
What this trial is testing

High-flow Conditioned Oxygen Therapy Versus Non-invasive Ventilation: Prevention of Post-extubation Failure

Who this might be right for
Post-extubation Respiratory Failure
Hospital Infanta Sofia 1,042
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Not applicableActive Not RecruitingNCT01936883
What this trial is testing

Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 195
Not applicableStudy completedNCT03083262
What this trial is testing

High Tone Pelvic Floor Dysfunction

Who this might be right for
Vulvovaginal Atrophy
St. Louis University 80
Large-scale testing (Phase 3)Study completedNCT04591275
What this trial is testing

Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .

Who this might be right for
Postmenopausal Osteoporosis
Shanghai Biomabs Pharmaceutical Co., Ltd. 278
Not applicableUnknownNCT05801705
What this trial is testing

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Who this might be right for
Hormone-receptor-positive Breast CancerPremenopausal Breast CancerBreast Cancer Patients at Intermediate to High Risk+1 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 700
Testing effectiveness (Phase 2)Study completedNCT01980056
What this trial is testing

Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy

Who this might be right for
Myelodysplastic Syndrome
Weill Medical College of Cornell University 10
Testing effectiveness (Phase 2)Ended earlyNCT01041027
What this trial is testing

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaStage IA Uterine Corpus CancerStage IB Uterine Corpus Cancer+6 more
Albert Einstein College of Medicine 31
Not applicableStudy completedNCT00274729
What this trial is testing

Mono Unsaturated Fatty Acids in Obesity - Weight Maintenance and Prevention of Lifestyle Diseases in Obese Subjects.

Who this might be right for
OverweightObesity
University of Copenhagen 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT01871766
What this trial is testing

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Who this might be right for
Rhabdomyosarcoma
St. Jude Children's Research Hospital 115
Not applicableUnknownNCT04473560
What this trial is testing

Catheter-directed Thrombectomy in High and Intermediate-high Risk Pulmonary Embolism

Who this might be right for
Pulmonary Embolism With Acute Cor Pulmonale
Poznan University of Medical Sciences 100
Testing effectiveness (Phase 2)Ended earlyNCT04264208
What this trial is testing

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Who this might be right for
Prostate Cancer
Andrei Iagaru 4
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06457425
What this trial is testing

A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis

Who this might be right for
MF,PMF,PPV-MF,PET-MF
Chengdu Zenitar Biomedical Technology Co., Ltd 75
Next Page